Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda ( IRON ‐M study)

Iron toxicity – Its effect on the bone marrow

(2018) Alessandro Isidori et al.   BLOOD REVIEWS

A storm in the niche: Iron, oxidative stress and haemopoiesis

(2018) Federica Pilo et al.   BLOOD REVIEWS

Sustained Erythroid Response in a Patient with Myelofibrosis Receiving Concomitant Treatment with Ruxolitinib and Deferasirox

(2018) Eugenio Piro et al.   CHEMOTHERAPY

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

(2015) Roberto Latagliata et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Effects of Iron Overload on the Bone Marrow Microenvironment in Mice

(2015) Yuchen Zhang et al.   PLoS One

IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

(2014) Elena Maria Elli et al.   Mediterranean Journal of Hematology and Infectious Diseases

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

(2012) Ayalew Tefferi et al.   MAYO CLINIC PROCEEDINGS